Product Information
BUPROPION HCL SR 100 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.0957 per EA under NDC 70436005802. Its NADAC has been published 230 times since Dec 23, 2020.
FDA first approved this application on Oct 16, 2018. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436005802
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211347FDA Approved
10/16/2018
TE Code
AB1
On Market Since
11/2/2020
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 100 MG TABLET has been published 230 times since Dec 23, 2020, and over the history we have for it it has declined 35.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0957 per EA |
|---|---|
| All-time high | $0.1536 (Mar 10, 2021) |
| All-time low | $0.0718 (Jul 17, 2024) |
| Median price | $0.1053 |
| Average price | $0.1084 |
| Largest weekly change | +30.2% (Jun 19, 2024) |
| Weeks tracked | 230 |
| Tracking since | Dec 23, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-17.1%
5Y
-27.3%
All
-35.0%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Slate Run Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 100 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.0957 per EA (NDC 70436005802), effective May 14, 2025.
How has the price of BUPROPION HCL SR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 100 MG TABLET has declined 35.0%. It has been tracked across 230 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 100 MG TABLET?
Since Dec 23, 2020, the NADAC for BUPROPION HCL SR 100 MG TABLET has ranged from a low of $0.0718 (Jul 17, 2024) to a high of $0.1536 (Mar 10, 2021), with a median of $0.1053 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 100 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL SR 100 MG TABLET, is $0.0679 per EA — about 29% below BUPROPION HCL SR 100 MG TABLET.
Who manufactures BUPROPION HCL SR 100 MG TABLET?
BUPROPION HCL SR 100 MG TABLET (NDC 70436005802) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.